Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It would be nice to know what TPL'S strategy

is for licensing. Of the hundreds that have been notified of infringement how many are we currently in negotiation with? Are they waiting for the MH or a settled T3 case? If we have an unfavorable MH and settle the case on less than favorable terms how bad does it hurt the MMP? Can we change strategy at that point and head back to EDOT by filing Law suits against the infringers? Does the old Markman ruling still stand or would we need a new one based on the re-exams. If I recall the re-exams actually clarified the asynchronous clock versus the language in the patent that claimed a synchronous clock. Was the previous MH flawed because of this. Does the MH have to use the strict language of the patent for the definitions. IMO our leverage might be strongest right now to get a gaggle of infringers to license. Hopefully TPL has communicated with the masses and let them know that fees will be rising significantly after the a positive MH and trial victory. I still have my boat ready waiting for that tsunami.

GL

Share
New Message
Please login to post a reply